Tuesday, 3 November 2026
M
Meridian Globe
Live briefing
Violent protests erupt in Swiss cities of Zurich and Basel— Tehran Times 德黑兰时报Thai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei AsiaOn India's east coast, tidepooling inspires marine conservation— 日经 Nikkei AsiaChina mega complex in Dalian puts spotlight on investment push— 日经 Nikkei AsiaTime for Japan to develop people who can sell content— 日经 Nikkei AsiaMitsubishi to sell part of stake in Canada LNG project to Blackstone funds— 日经 Nikkei AsiaJapan's SBI to invest in US digital bank Erebor, eyeing blockchain settlements— 日经 Nikkei AsiaViolent protests erupt in Swiss cities of Zurich and Basel— Tehran Times 德黑兰时报Thai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei AsiaOn India's east coast, tidepooling inspires marine conservation— 日经 Nikkei AsiaChina mega complex in Dalian puts spotlight on investment push— 日经 Nikkei AsiaTime for Japan to develop people who can sell content— 日经 Nikkei AsiaMitsubishi to sell part of stake in Canada LNG project to Blackstone funds— 日经 Nikkei AsiaJapan's SBI to invest in US digital bank Erebor, eyeing blockchain settlements— 日经 Nikkei Asia

Fresenius Taps China’s WuXi to Expand Biosimilar Drug Portfolio

Source Bloomberg 财经7h ago
Summary

Fresenius SE agreed to partner with Chinese contract drug developer WuXi Biologics on biosimilar candidates that could reach the market in the next decade, pot…

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Business
Region
Americas
Language
English
Item ID
business-d4188171

Comments 0 comments

No comments yet. Be the first.

Fresenius Taps China’s WuXi to Expand Biosimilar Drug Portfolio · Meridian Globe